Anti-allergic activity of compounds from Boesenbergia thorelii

Boesenbergia thorelii extract of rhizomes and its compounds were investigated for anti-allergic activities usingantigen-induced -hexosaminidase release in RBL-2H3 cells. From bioassay-guided fractionation, the chloroform fraction wasseparated to afford four compounds: asaronaldehyde (1), -sitoster...

Full description

Bibliographic Details
Main Authors: Supinya Tewtrakul, Fameera Madaka, Chatchai Wattanapiromsakul, Teeratad Sudsai
Format: Article
Language:English
Published: Prince of Songkla University 2013-04-01
Series:Songklanakarin Journal of Science and Technology (SJST)
Subjects:
Online Access:http://rdo.psu.ac.th/sjstweb/journal/35-2/35-2_197-101.pdf
id doaj-a6e0f12ab49b486bb93ce56aef67a09f
record_format Article
spelling doaj-a6e0f12ab49b486bb93ce56aef67a09f2020-11-25T00:15:33ZengPrince of Songkla UniversitySongklanakarin Journal of Science and Technology (SJST)0125-33952013-04-01352197101Anti-allergic activity of compounds from Boesenbergia thoreliiSupinya TewtrakulFameera MadakaChatchai WattanapiromsakulTeeratad SudsaiBoesenbergia thorelii extract of rhizomes and its compounds were investigated for anti-allergic activities usingantigen-induced -hexosaminidase release in RBL-2H3 cells. From bioassay-guided fractionation, the chloroform fraction wasseparated to afford four compounds: asaronaldehyde (1), -sitosterol-D-glucoside (2), protocatechuic acid methyl ester (3)and 2-hydroxy-1-(3, 4-dimethoxyphenyl) ethanols (4). Their structures were elucidated on the basis of UV, IR and NMRspectroscopic data. Of these, compound 1 (asaronaldehyde) was the most active with an IC50 value of 24.3 µM, followed by2 (IC50 = 63.3 µM) and 4 (IC50 = 72.6 µM); whereas compound 3 was inactive (IC50 > 100µM). Anti-allergic effect of 1 (IC50 =24.3 µM) was higher than that of ketotifen fumarate (IC50 = 41.1 µM), the positive control. This study may support the useof B. thorelii for treatment of allergy-related diseases. Moreover, this is the first report on biological study and chemicalconstituents of B. thorelii.http://rdo.psu.ac.th/sjstweb/journal/35-2/35-2_197-101.pdfRBL-2H3 cellsanti-allergic activityBoesenbergiathorelii
collection DOAJ
language English
format Article
sources DOAJ
author Supinya Tewtrakul
Fameera Madaka
Chatchai Wattanapiromsakul
Teeratad Sudsai
spellingShingle Supinya Tewtrakul
Fameera Madaka
Chatchai Wattanapiromsakul
Teeratad Sudsai
Anti-allergic activity of compounds from Boesenbergia thorelii
Songklanakarin Journal of Science and Technology (SJST)
RBL-2H3 cells
anti-allergic activity
Boesenbergiathorelii
author_facet Supinya Tewtrakul
Fameera Madaka
Chatchai Wattanapiromsakul
Teeratad Sudsai
author_sort Supinya Tewtrakul
title Anti-allergic activity of compounds from Boesenbergia thorelii
title_short Anti-allergic activity of compounds from Boesenbergia thorelii
title_full Anti-allergic activity of compounds from Boesenbergia thorelii
title_fullStr Anti-allergic activity of compounds from Boesenbergia thorelii
title_full_unstemmed Anti-allergic activity of compounds from Boesenbergia thorelii
title_sort anti-allergic activity of compounds from boesenbergia thorelii
publisher Prince of Songkla University
series Songklanakarin Journal of Science and Technology (SJST)
issn 0125-3395
publishDate 2013-04-01
description Boesenbergia thorelii extract of rhizomes and its compounds were investigated for anti-allergic activities usingantigen-induced -hexosaminidase release in RBL-2H3 cells. From bioassay-guided fractionation, the chloroform fraction wasseparated to afford four compounds: asaronaldehyde (1), -sitosterol-D-glucoside (2), protocatechuic acid methyl ester (3)and 2-hydroxy-1-(3, 4-dimethoxyphenyl) ethanols (4). Their structures were elucidated on the basis of UV, IR and NMRspectroscopic data. Of these, compound 1 (asaronaldehyde) was the most active with an IC50 value of 24.3 µM, followed by2 (IC50 = 63.3 µM) and 4 (IC50 = 72.6 µM); whereas compound 3 was inactive (IC50 > 100µM). Anti-allergic effect of 1 (IC50 =24.3 µM) was higher than that of ketotifen fumarate (IC50 = 41.1 µM), the positive control. This study may support the useof B. thorelii for treatment of allergy-related diseases. Moreover, this is the first report on biological study and chemicalconstituents of B. thorelii.
topic RBL-2H3 cells
anti-allergic activity
Boesenbergiathorelii
url http://rdo.psu.ac.th/sjstweb/journal/35-2/35-2_197-101.pdf
work_keys_str_mv AT supinyatewtrakul antiallergicactivityofcompoundsfromboesenbergiathorelii
AT fameeramadaka antiallergicactivityofcompoundsfromboesenbergiathorelii
AT chatchaiwattanapiromsakul antiallergicactivityofcompoundsfromboesenbergiathorelii
AT teeratadsudsai antiallergicactivityofcompoundsfromboesenbergiathorelii
_version_ 1725386193062854656